The DNA FACE™ concept has been successfully used to develop prototype pro-regenerative drug. The EP 3.549.947.B1 patent is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk, Gdańsk Medical University and Gdańsk Technical University financed by R&D grant from The National Centre for Research and Development STRATEGMED1/235077/9/NCBR/2014 (2014-2017): “Novel technologies for pharmacological stimulation of regeneration.”
Comments